Sponsor & Developer Portfolio
University of Florida
Clinical development pipeline, platform architecture, and registered trial tracking for University of Florida vaccine candidates.
1
Candidates
1
Target Diseases
1
Linked Studies
Development Phase Distribution
Phase 2 Clinical Trial: 1
Platform Technologies
mRNA: 1
Target Pathogens & Indications
Stage 4 NSCLC
Vaccine Pipeline Candidates (1)
Detailed candidate profiles, clinical phases, target indications, and anticipated milestones.
Phase 2 Clinical Trial
ctgov-pfizer-biontech-mrna-covid-19-vaccine-university-of-florida
Pfizer-BioNTech mRNA COVID-19 vaccine
Target: Stage 4 NSCLC
Platform: mRNA
Key Milestone: Primary completion (most advanced trial): 2035-03 (registry estimate)
Explore Other Vaccine Developers & Sponsors
Compare pipeline volume, phase progression, and modalities across global biopharmaceutical manufacturers.